Clinical Trial Update: A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vaccine [Phase 3]

View source ↗

Summary

A multi-center, open-label, randomized, controlled Phase 3 trial evaluating the sIPV vaccine for poliomyelitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• sIPV vaccine (Sabin inactivated poliovirus vaccine (sIPV))

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Poliomyelitis, Polio | Phase 3 | Status: COMPLETED